Related Experiment Videos
Nortriptyline: a model drug in geriatric depression
1New York Hospital-Cornell Medical Center, White Plains.
Clinical Neuropharmacology
|January 1, 1992
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.
American journal of reproductive immunology (New York, N.Y. : 1989)·2000
Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.
Journal of the National Medical Association·2000
Up-regulation of epidermal growth factor-receptors (EGF-R) by nicotine in cervical cancer cell lines: this effect may be mediated by EGF.
American journal of reproductive immunology (New York, N.Y. : 1989)·2000
Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.
Clinical neuropharmacology·2026
Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.
Clinical neuropharmacology·2026
A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.
Clinical neuropharmacology·2026
Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.
Clinical neuropharmacology·2026
Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.
Clinical neuropharmacology·2026
Evaluation of Bronchial Receptors with Concentration-Response Curves, Bitterness Assessment, and Computer Simulations.
Cell biochemistry and biophysics·2026
Lead (Pb) and the NMDA Receptor Hypofunction Hypothesis: A Comparative Review of Non-Essential Metal Exposures in Schizophrenia.
Current environmental health reports·2026
Open-label placebo effects on psychological distress and hair cortisol in a randomized controlled trial - the moderating role of the five-factor personality traits.
Comprehensive psychoneuroendocrinology·2026